Concepedia

Juan José García Sánchez

JJ

Statistics

Publications

23

Citations

1.2K

H-Index

16

Active since

2008

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (United States)

University College London

AstraZeneca (Sweden)

The University of Sydney

Juan José García Sánchez is an author at AstraZeneca (United Kingdom) specializing in chronic kidney disease, renal disease, and medicine.

Publications per year

2008–2024

23

Publications

23

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

Ramón C. Hermida, Juan J. Crespo, Manuel Domínguez-Sardiña et al. · European Heart Journal · 2019 · 448 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention

Ramón C. Hermida, Juan J. Crespo, Alfonso Otero et al. · European Heart Journal · 2018 · 134 citations · Full text

Medicine, Internal Medicine, Preventive Medicine +17

An analog front-end enables electrical impedance spectroscopy system on-chip for biomedical applications

Fernando Seoane, Javier Ferreira, Juan José García Sánchez et al. · Physiological Measurement · 2008 · 101 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

Projecting the economic burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study

Steven J. Chadban, Mustafa Arıcı, Albert Power et al. · EClinicalMedicine · 2024 · 68 citations · Full text

Pharmacy, Health Policy, Pharmacoeconomics +17

Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease

Phil McEwan, Oliver Darlington, Ryan Miller et al. · Clinical Journal of the American Society of Nephrology · 2022 · 64 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

1–5 of 23